Free Trial
NYSEAMERICAN:DXR

Daxor (DXR) Stock Price, News & Analysis

Daxor logo
$8.06 -0.08 (-0.92%)
As of 10:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Daxor Stock (NYSEAMERICAN:DXR)

Key Stats

Today's Range
$7.98
$8.13
50-Day Range
$7.20
$8.33
52-Week Range
$6.55
$10.00
Volume
1,276 shs
Average Volume
8,693 shs
Market Capitalization
$38.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Receive DXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter.

DXR Stock News Headlines

Daxor expands blood volume analysis technology across three networks
Daxor expands BVA services at Midwest healthcare facility
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?
Daxor announces case series published in JACC
Daxor expands ezBVA Lab service to two new hospital systems
See More Headlines

DXR Stock Analysis - Frequently Asked Questions

Daxor's stock was trading at $7.9350 at the beginning of the year. Since then, DXR shares have increased by 1.5% and is now trading at $8.0550.
View the best growth stocks for 2025 here
.

Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Daxor investors own include Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD), Novavax (NVAX), iBio (IBIO), CRISPR Therapeutics (CRSP) and Dynavax Technologies (DVAX).

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:DXR
Previous Symbol
NYSE:DXR
Employees
37
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
1,866,000
Market Cap
$38.32 million
Optionable
Not Optionable
Beta
-0.50
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSEAMERICAN:DXR) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners